当前位置: 首页 > 期刊 > 《中外医疗》 > 201525
编号:13633525
神经病理性疼痛的实验及治疗现状研究(3)
http://www.100md.com 2015年9月5日 《中外医疗》 201525
     [7] Ngernyam N, Jensen MP, Arayawichanon P, et al. The effects of transcranial direct current stimulation in patients with neuropathic pain from spinal cord injury[J].Clin Neurophysiol, 2015, 126(2):382-390.

    [8] Matsushita K, Tozaki-Saitoh H,Kojima C, et al.Chemokine (C-C motif) receptor 5 is an important pathological regulator in the development and maintenance of neuropathic pain[J].2014,120(6):1491-503.

    [9] Ney JP, Devine EB, Watanabe JH, et al. Comparative efficacy of oral pharmaceuticals for the treatment of chronic peripheral neuropathic pain: meta-analysis and indirect treatment comparisons[J]. Pain medicine(Malden, Mass.),2013, 14(5):706-719.

    [10] Niccola? P, Ouchchane L, Libier M,et al.Persistent neuropathic pain after inguinal herniorrhaphy depending on the procedure (open mesh v. laparoscopy): a propensity-matched analysis[J].Canadian journal of surgery. Journal canadien de chirurgie,2014,58(2):114-20.

    [11] Wang C, Wang H, Pang J, et al. Glial cell-derived neurotrophic factor attenuates neuropathic pain in a mouse model of chronic constriction injury: possible involvement of E-cadherin/p120ctn signaling[J].Journal of molecular neuroscience : MN,2014,54(2):156-63.

    [12] Gu N,Niu JY,Liu WT,et al. Hyperbaric oxygen therapy attenuates neuropathic hyperalgesia in rats and idiopathic trigeminal neuralgia in patients[J].European journal of pain (London, England), 2012, 16(8):1094-1105.

    (收稿日期:2015-06-07), http://www.100md.com(喻海春 孙广运)
上一页1 2 3